Glaxo defends safety of weight loss drug alli
WASHINGTON — British drugmaker GlaxoSmithKline is scrambling to shore up the safety image of its weight loss pill alli, after watching sales dive on news that federal regulators are investigating the drug.
NJ: 29 hepatitis B cases tied to one doctor
JERSEY CITY, N.J. — New Jersey health officials are urging 2,000 more patients to get tested for hepatitis B and other blood-borne diseases following an outbreak linked to a single doctor’s office.
NJ: 29 hepatitis cases tied to 1 doctor’s office
TRENTON, N.J. — Several thousand patients of a New Jersey doctor should get tested for blood-borne diseases because of an outbreak linked to his office that has led to more than two dozen being diagnosed with hepatitis B, state health officials said.